L’activation de la signalisation NF-κB par de nombreux immunorécepteurs met en jeu un large signalosome. Afin de propager cette signalisation en réponse à différents stimuli, l’oligomérisation d’adaptateurs pourvus de domaines d’interaction protéine-protéine est nécessaire. Alors que certains adapteurs sont communs d’autres sont spécifiques à un immunorécepteur donné. Une des principales caractéristiques partagées par toutes ses protéines est leur capacité à être poly-ubiquitinylé de façon non-dégradative afin d’aboutir à une activation optimale de NF-κB. Ce projet avait pour objectif d’identifier de nouvelles déubiquitinylases impliquées dans la signalisation NF-κB. C’est ainsi que nous avons identifié USP34 comme étant un régulateur négatif de la signalisation NF-κB induite par le TCR dans des cellules Jurkats, une lignée de lymphocytes T immortalisés. Nos données suggèrent un modèle dans lequel USP34 permet d’éviter l’activation excessive de NF-κB, en agissant directement ou indirectement sur les dimères NF-κB/IκBα, en aval d’IKK, et en modulant l’affinité du facteur de transcription pour l’ADN. Parallèlement, l’étude du microenvironnement des membranes endocellulaires responsables du recrutement des signalosomes formés en réponse à l’activation du TCR, du TNFR et du CD40 a permis l’identification d’une protéine - clé de la signalisation NF-κB, la MTDH. Cette protéine du RE s’est révélée être un relais déterminant pour l’activation d’IKK et donc la propagation du signal NF-κB. / Large signalosome assembly is a prerequisite for NF-κB signaling upon engagement of various immunoreceptors. Adaptor proteins containing protein-protein interaction domains oligomerise in response to such stimuli in order to propagate signaling. Each immunoreceptor uses distinct adaptors, as well as common ones, to achieve that. The main characteristic shared by these proteins is their ability to undergo poly-ubiquitinylation in a non-degradative manner, leading to optimal NF-κB activation. In this work, we aimed to identify novel deubiquitinylating enzymes that control ubiquitinylation status. That is how USP34 came up to be a negative regulator of NF-κB signaling in TCR-activated Jurkat cells, a T lymphocyte cell line. Our data suggest a model whereby USP34 prevents excessive NF-κB activation by acting rather late, directly or indirectly on the NF-κB:IκBα dimers, downstream of IKK, altering transcription factor DNA binding affinity. In parallel, studies of the endocellular membrane microenvironment that hosts mature signalosomes in response to TCR-, TNFR- and CD40 ligation led to the identification of an ER-residing protein, Metadherin (MTDH), which seems to globally integrate signaling before forwarding it to downstream pathway components able to activate IKK.

Polychlorinated biphenyls (PCBs) are nongenotoxic hepatic tumor promoters. PCBs have been shown to cause oxidative stress, but the exact mechanism by which PCBs exert their tumor promoting activity is not clear. In our study, PCB-153, a non-coplanar congener, caused a transient increase in hepatic NF-B DNA binding activity and cell proliferation, while PCB-77, a coplanar congener, showed no effect. Our second study using a mouse model that was deficient in the p50 subunit of NF-kB (p50-/-) showed that NF-kB contributes to the changes in hepatocyte proliferation and apoptosis in response to PCB-153 treatment: a single dose of PCB-153 increased hepatic NF-B activity and cell proliferation in wild type mice, but not in the p50-/- mice; longer-term treatment with PCB-153 increased cell proliferation in p50-/- mice, but this increase was less than that in the wild type. In addition, p50-/- livers had more apoptosis than in the wild type, and PCB-153 inhibited apoptosis in the p50-/- livers. p50-/- livers had less cyclin D1 protein than the wild type, but that the mRNA levels were same. Bcl-xL protein was not changed by PCB-153, and wild type and p50-/- mice had the same level of Bcl-xL protein. In the third study, PCB-77 caused an increase in hepatic NF-kB DNA binding activity and cell proliferation during the promotion stage, and this increase was blocked by dietary supplementation of vitamin E, but the number and volume of placental glutathione S-transferase (PGST)-positive foci were slightly, though insignificantly, increased in the same animals. The apparent conflict could be due to different effect in different cells: high level vitamin E significantly inhibited PCB-77-induced cell proliferation in normal hepatocytes, while this inhibitory effect was much less in the PGST-positive hepatocytes. In conclusion, our studies show that a non-coplanar PCB can cause an increase in hepatic NF-kB DNA binding activity in rats and mice, and this increase contributes to the change in cell proliferation and apoptosis. Dietary vitamin E supplementation did not show protective effect on the formation of altered hepatic foci that were promoted by PCBs, although vitamin E supplementation decreased PCBs-induced hepatic NF-kB activation and cell proliferation.

ABSTRACT Metformin is the most common drug used against type 2 diabetes mellitus. However, it was only recently shown, in human and rat hepatocytes, that metformin-like 5-aminoimidazole-4-carboximide ribonucleoside (AICAR), acts via activation of the AMP-activated protein kinase (AMPK), an enzyme that plays a central role in lipid metabolism. Although it is well known that metformin is used in the treatment of type 2 diabetes and results in significant fat loss, no study has investigated the effects of this drug on adipocytes. In this report I studied the effects of metformin on the formation of fat deposits in mouse 3T3-L1 preadipocytes, as well as its effects on the activation of AMPK in these cells. Our results suggested that metformin significantly inhibits the transformation of pre-adipocytes into adipocytes. This is achieved via the inhibition of intracellular lipid accumulation during adipogenesis. In addition to its inhibition of intracellular lipid accumulation, metformin induced a significant increase in the phosphorylation of AMPK. It has been shown that AMPK activation with AICAR results in the inhibition of the nuclear factor-κB (NF-κB) induced gene expression. Since NF-κB is the key nuclear factor used by HIV-1 during the initiation of its gene transcription, I investigated the possibility of inhibiting HIV-1 replication in U1 cells with metformin and AICAR. I observed that AICAR and metformin inhibit HIV-1 replication in U1 cells. This inhibition wasparalleled by the accumulation of NF-κB in the cytoplasm of AICAR and metformin treated cells, and at the same time by a significant decrease in the concentration of this nuclear factor in the nucleus of these cells. However, I failed to observe any phosphorylation of AMPK by metformin and AICAR in U1 cells. In conclusion, metformin inhibits adipogenesis in mouse adipocytes and this inhibition is likely to take place via the activation of AMPK. AICAR and metformin have inhibitory properties against HIV-1 replication. However, this inhibition does not seem to be by the activation of AMPK.

Submitted by FERNANDA DA SILVA VON PORSTER (fdsvporster@univates.br) on 2016-09-22T19:02:03Z No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) 2016JulianoLeipelt.pdf: 2508061 bytes, checksum: 100e43c73eddacc8441a11de473e260c (MD5) / Approved for entry into archive by Ana Paula Lisboa Monteiro (monteiro@univates.br) on 2016-09-29T19:20:07Z (GMT) No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) 2016JulianoLeipelt.pdf: 2508061 bytes, checksum: 100e43c73eddacc8441a11de473e260c (MD5) / Made available in DSpace on 2016-09-29T19:20:08Z (GMT). No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) 2016JulianoLeipelt.pdf: 2508061 bytes, checksum: 100e43c73eddacc8441a11de473e260c (MD5) Previous issue date: 2016-09 / O câncer é apontado como a segunda maior causa de morte em todo o mundo, com previsão de em breve ser tornar a primeira. O câncer de próstata está entre os 5 tipos de câncer mais diagnosticados em homens, sendo que o câncer hepático está em segundo lugar em taxa de mortalidade entre homens e mulheres. Indícios apontam para uma ativação das vias da inflamação associados a uma inibição das vias de morte celular no processo de carcinogênese. A regulação destas vias torna-se alvo importante e complementar no controle do câncer, sendo estimulada a busca de biomoléculas com este potencial. As plantas são importante fonte de descoberta de novas biomoléculas com ampla utilização para o tratamento de diversas patologias. A família Myrtaceae possui diversas espécies que são apontadas como fortes candidatos em potencial nesta busca, incluindo as do gênero Myrciaria. A espécie Myrciaria plinioides não possui estudos referentes suas propriedades terapêuticas ou a atuação em vias de sinalização envolvidas na inflamação ou na carcinogênese. Neste contexto, este estudo teve por objetivo avaliar a atividade do extrato etanólico de M. plinioides em células de carcinoma hepatocelular (HepG2) e próstata (LNCaP) , através da análise de expressão dos marcadores p38-α, pp38-α, NF-κB e caspase-3, envolvidos na carcinogênese, e o efeito sobre a viabilidade celular através do método de MTT. A viabilidade das células foi alterada significativamente, em ambas as linhagens celulares quando tratadas com o extrato etanólico. A análise da expressão proteica demonstra significativa inibição da expressão de p38-α e caspase-3 nas células LNCaP, quando tratadas com extrato etanólico de M. plinioides seguido de LPS. Em células HepG2, somente houve alteração na expressão da caspase-3 na concentração de 200 μg/mL, com ou sem adição de LPS após tratamento com extrato. Os resultados deste estudo demonstraram redução da viabilidade celular nas duas linhagens tumorais, expressão diferenciada de proteínas envolvidas em apoptose, o que leva a indícios da ativação de mecanismos distintos pelo extrato em cada tipo celular. Estudos futuros para averiguar o mecanismo celular e a indução de morte em células tumorais de câncer de próstata e de fígado podem contribuir para a identificação e elucidação de novas biomoléculas com potencial antitumoral. / Cancer is touted as the second leading cause of death worldwide, forecast to soon be making the first. Prostate cancer is among the five most cancers diagnosed in men, and liver cancer is second in mortality between men and women. Evidence points to the activation of pathways of inflammation associated with an inhibition of cell death pathways in carcinogenesis. The regulation of these pathways becomes important and complementary target in cancer control, and stimulated the search for biomolecules with this potential. The plants are important source of discovery of new biomolecules with wide use for the treatment of various diseases. The Myrtaceae family has many species that are identified as potential candidates strong in this search, including the Myrciaria genre. The species Myrciaria plinioides not have studies on its therapeutic properties or performance in signaling pathways involved in inflammation or carcinogenesis. In this context, this study aimed to evaluate the activity of the ethanol extract of M. plinioides in hepatocellular carcinoma cells (HepG2) and prostate (LNCaP) by expression analysis of p38-α markers, PP38-α, NF-kB and caspase-3, involved in carcinogenesis, and the effect on cell viability by the MTT method. The viability of cells was significantly altered in both cell lines when treated with ethanolic extract. Protein expression analysis demonstrates significant inhibition of p38-α expression and caspase-3 in LNCaP cells, when treated with ethanolic extract of M. plinioides followed by LPS. In HepG2 cells there was only a change in the expression of caspase-3 at a concentration of 200 / ml, with or without addition of LPS after treatment with extract. The results showed reduction of cell viability in both tumor lines, differential expression of proteins involved in apoptosis, leading to evidence of activation by distinct mechanisms in each extract cell type. Further studies to investigate the cellular mechanism, and induction of death in tumor cells of prostate and liver cancer may contribute to the identification and elucidation of new biomolecules with antitumor potential.

Immune cells must accurately interpret environmental signals to make robust cell fate decisions and control inflammatory signalling. Many signals (e.g. Tumor Necrosis Factor alpha (TNFα) or interferon gamma (IFNγ)) converge on just a few key signalling systems such as Nuclear Factor kappa B (NF-κB) or Signal Transducers and Activators of Transcription (STAT), which exhibit complex activation dynamics that control patterns of downstream gene expression. Often, seemingly identical cells show heterogeneous or random behaviour to a common stimulus. Therefore, a key question is how can immune cells coordinate inflammatory signalling in the presence of this noise. The NF-kB system dynamics were studied in response to rapidly changing inflammatory signals. It was shown that pulsed TNFa cytokine stimulations induced digital single-cell NF-kB responses, with only a fraction of cells able to respond to repeated pulses. These responses appeared to be reproducible in individual cells, but heterogeneous in the population. Mathematical models of the NF-kB signalling network suggested that single-cell responses were governed through a refractory state potentially encoded via 'extrinsic' noise in the levels of signalling molecules related to the TNFa signal transduction pathway. Such signal processing enabled robust and reproducible single cell responses and maintained acute tissue-level signalling, with fewer cells responding to shorter pulsing intervals. The NF-kB system is involved in effector cytokine propagation in response to pathogen infection. It was shown that in macrophages, the dose of TLR4 stimulation (mimicking the pathogen infection) was encoded in graded (yet heterogeneous) NF-kB dynamics in single cells. This resulted in analogue inflammatory gene expression patterns in the population. However, individual cells substantially differed in their ability to encode TLR4 signal and to regulate TNFa expression, which was explained by extrinsic noise in the NF-kB system. Quantitative mathematical modelling showed that tissue-level environment modulates heterogeneous single-cell TNFa outputs; by effectively removing it from circulation. This may determine the interaction distance between tissue-resident immune cells to enable propagation of cellular inflammation. Heterogeneity of single cell macrophage signalling was also observed in NF-kB and STAT1 system responses to a range of IFN stimulation doses. Although each system showed substantial variability between cells, their responses were surprisingly well correlated in individual cells. It was however apparent (based on gene expression studies) that individual cells may not be able to precisely discriminate different IFNg doses. Overall, this work suggests that heterogeneity in the NF-kB (and other) regulatory networks might be a part of an inherent design motif in the inflammatory response, which enables robust control of the tissue-level inflammatory response by preventing homogeneous and thus potentially harmful activation.

CD40 is a TNF-Receptor (TNFR) superfamily member that functions to promote several facets of the humoral immune response--including B cell proliferation, differentiation, antibody isotype switching, and cytokine expression. TNFR superfamily members lack intrinsic kinase activity and must recruit members of the TNFR-associated factor (TRAF) family of adaptor proteins to connect the receptor to intracellular signaling pathways. CD40-mediated JNK and NF-κB activation is critical for an intact humoral immune response; however, the precise mechanisms governing the spatiotemporal activation of these pathways are not completely understood. In this study we report that CD40 ligation results in the dual phosphorylation of TRAF2 on Ser-11 and Ser-55 to control the subcellular localization of key pathway intermediates and temporally regulate downstream JNK and IKK/NF-κB pathway activation. Notably, TBK1- mediated TRAF2 Ser-11 phosphorylation elicits the dissociation of a signaling complex, consisting of TRAF2, cIAP1/2, and IKKγ, from the CD40 receptor to potentiate a secondary phase of JNK and IKK activation. In the absence of this phosphorylation event, these proteins translocate to the insoluble lipid rafts along with the membrane-bound receptor complex, where TRAF2 undergoes Ser-55 phosphorylation-dependent self-ubiquitination and degradation necessary for cessation of JNK activation. Furthermore, TRAF2 Ser-11 phosphorylation inhibits non-canonical NF-κB activation by promoting the lipid raft localization of the CD40 receptor complex. This suggests that TRAF2 dual phosphorylation acts as a molecular switch to control canonical and non-canonical NF-κB activation. CD40 signaling is heavily implicated in a wide array of chronic inflammatory and autoimmune diseases--including Alzheimer's, Grave's disease, and diabetes. As such, characterization of the molecular mechanisms directing CD40 signal transduction will provide a foundation for the further development of targeted immunomodulatory therapeutics. In addition, the NF-κB transcriptional program has well-defined roles in oncogenesis and tumor progression, and many B cell lymphomas exploit the CD40L/CD40 dyad to constitutively activate the NF-κB pathway and potentiate neoplastic growth and survival. Through these analyses, we demonstrate that TRAF2 phosphorylation on Ser-11 and Ser-55 promote cell survival in response to genotoxic and oxidative stress, respectively, by regulating JNK and NF-κB pathway activation and coordinating the subcellular localization and stability of key signaling effectors. Furthermore, we show that inhibition of TRAF2 phosphorylation in B-cell lymphoma cells increases their sensitivity to standard frontline chemotherapeutics, including doxorubicin and vincristine, as well as the novel agents bortezomib and arsenic trioxide. These findings are clinically significant, as TRAF2 is found over-expressed and constitutively phosphorylated in DLBCL cell lines and patient biopsies. In addition, mice bearing tumors that harbor TRAF2 Ser-11 phospho-null mutations are more responsive to treatment with doxorubicin and have significantly prolonged survival compared to wild-type counterparts in a syngeneic model of B-cell lymphoma. The tumor microenvironment is characterized by pro-inflammatory cytokines, hypoxia, low glucose, and free radicals, all of which are known to induce chronic cellular stress and NF-κB activation. Cancer cell adaptation to these stressors has profound consequences for malignant progression and therapeutic response. In this regard, our findings present a unique opportunity where the molecular targeting to TRAF2 phosphorylation could increase the efficacy of current therapies by suppressing basal NF-κB activation, thus synergistically sensitizing NF-κB-driven malignancies to chemotherapeutic-induced cell death.

Schwann cells (SCs) are crucial for peripheral nerve development and regeneration; however, the intrinsic regulatory mechanisms governing post-injury responses are poorly understood. Activation and deacetylation of nuclear factor-κB (NF- κB) in SCs have been implicated as prerequisites for peripheral nerve myelination. Using GFAP-IκBα-dn mice, in which NF- κB transcriptional activation is inhibited in SCs, we found no discernable differences in the quantity or structure of myelinated axons in adult facial nerves. Following crush injury, axonal regeneration was impaired at 31 days and greatly improved at 65 days in GFAP-IκBα-dn mutants. Compact re-myelination and sensory fiber organization were significantly compromised at 31 days and restored by 65 days. Together, these data indicate that NF- κB activation in SCs is dispensable for peripheral nerve myelination in adults, but required for early re-myelination and axonal regeneration. SC myelination during development and following injury in adult mice may hinge on different transcriptional cascades; these findings may offer new therapeutic avenues for PNS and CNS regeneration.

Le facteur de transcription NF-κB joue un rôle majeur dans lorchestration de nombreux processus biologiques, tels que les réponses immunitaires innée et adaptative, la division cellulaire, lapoptose et le développement. Le NF-κB est activé en réponse à un grand nombre de stimuli, comme les cytokines pro-inflammatoires, les agents viraux et bactériens et la stimulation antigénique des cellules du système immunitaire. Il peut être aussi activé dans des conditions de stress oxydant, par exemple après une exposition à des concentrations physiologiques (de lordre du µM) de peroxyde dhydrogène (H2O2). Au début de ce travail, le mécanisme conduisant à lactivation du NF-κB par le stress oxydant était mal connu et sujet à maintes controverses, ce qui nous a poussé à investiguer cette voie plus avant. Dans une première partie, nous nous sommes attachés à étudier le mécanisme dactivation du NF-κB dans des lymphocytes T soumis à un stress oxydant. Les cellules du système immunitaire sont en effet très sensibles à lenvironnement redox, et sont fréquemment en contact avec des espèces réactives de loxygène libérées par les cellules phagocytaires (monocytes/macrophages et neutrophiles) lors dune réponse inflammatoire. Comme le NF-κB est une protéine cruciale pour le développement et lhoméostasie des lymphocytes T, létude de sa modulation lors dun stress oxydant savère particulièrement importante. Nous avons pu mettre en évidence une activation importante du facteur de transcription lors dun traitement oxydant, ainsi quune dégradation presque compète de linhibiteur IκBα. Létude approfondie du mécanisme menant à cette dégradation a mis au jour un mécanisme dactivation tout à fait inédit, impliquant lactivation du complexe IKK via lintervention de lInositol Phosphatase SHIP-1. Dans cette première partie, nous avons également mis en évidence le rôle crucial de la protéine SHIP-1 dans la protection des lymphocytes T contre lapoptose induite par le stress oxydant, ce qui en fait une protéine clé dans la lhoméostasie des lymphocytes T. Dans un second temps, nous nous sommes intéressés au mécanisme influençant la fixation du NF-κB à lADN. Nous avons pu démontrer le rôle important de la protéine IKKα comme déterminant la fixation du NF-κB aux promoteurs de certains gènes, mettant ainsi au jour un mode daction inconnu pour cette protéine. Ce rôle est dautant plus intéressant quil est spécifique, ce qui pourrait déboucher sur des applications thérapeutiques intéressantes.

The lysosomal-associated protein transmembrane 5 (LAPTM5) is a protein preferentially expressed in the immune cells. LAPTM5 was isolated in our laboratory as an interacting partner of the ubiquitin ligase, Nedd4. The intracellular domains of LAPTM5 contain three PY (L/PPxY) motifs, which bind the WW domains of Nedd4, as well as a ubiquitin-interacting motif (UIM). Here, I show that sorting of LAPTM5 from the Golgi to the lysosomes requires its association with Nedd4 and the clathrin adaptor GGA3. Although the Nedd4-LAPTM5 interaction leads to the ubiquitination of LAPTM5, this event is not necessary for LAPTM5 sorting. Rather, the Nedd4-LAPTM5 complex recruits ubiquitinated GGA3, which binds the UIM of LAPTM5. Hence, I propose a novel mechanism by which the ubiquitin ligase Nedd4, via interactions with GGA3 and cargo (LAPTM5), regulates cargo trafficking to the lysosome without requiring cargo ubiquitination. Because nothing was known about the biological function of LAPTM5, at the beginning of my Ph.D. training, I set out to determine the role of LAPTM5 in the innate immune cells. I demonstrate that LAPTM5 interacts with kinesin, a motor protein previously implicated in the anterograde movement of the late endosomal/lysosomal compartments. In dendritic cells, I show that upon maturation LAPTM5 is present within endolysosomal tubules formed by class II MHC molecules. Although I find that LAPTM5 is dispensable for the translocation of peptide-loaded MHC II molecules to the cell surface, this study extends our knowledge of the repertoire of proteins present within tubules formed by the MHC II compartments in activated dendritic cells. In macrophages, I demonstrate that LAPTM5 acts as a positive regulator of NFκB and MAPK signaling cascades, and promotes efficient proinflammatory cytokine production in response to several inducers of macrophage activation. During TNFα stimulation, LAPTM5 is required for proper initiation of NFκB signaling by acting at the receptor-proximate level. Thus, my findings indicate that LAPTM5 is an important component of inflammatory signaling cascades in macrophages and highlight a role for the endosomal/lysosomal system in regulating these cascades. Collectively, the work presented in this thesis broadens our understanding of lysosomal membrane protein sorting and function.

Glucocorticoids are exploited for the treatment of hematological malignancies due to their ability to cause apoptosis in lymphoid cells. Innate and acquired resistance, however, limits their efficacy in the clinic. The mechanisms contributing to resistance are poorly understood. A better understanding of the critical events during glucocorticoid-induced apoptosis are needed in order to develop novel agents that will exploit these critical targets and improve the response to glucocorticoid-based therapies. Previously, using WEHI7.2 murine thymic lymphoma cells, our laboratory demonstrated that the levels of reactive oxygen species (ROS) increase during glucocorticoid-induced apoptosis signaling. WEHI7.2 cell variants with increased catalase exhibit increased resistance to glucocorticoids, suggesting that oxidative stress plays a role in glucocorticoid-induced apoptosis and that increasing the intracellular production of ROS may be a potential strategy for sensitizing lymphoma cells to glucocorticoid treatment. The following studies demonstrate that an increase in H₂O₂ is essential for lymphoma cells to undergo apoptosis and that the ability to remove cellular H₂O₂ protects the cells from glucocorticoid-mediated cell death. The redox-cycling agent, Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl) porphyrin, increased glucocorticoid-induced oxidative stress in WEHI7.2 cells and sensitized the cells to glucocorticoid treatment. MnTE-2-PyP⁵⁺ glutathionylated NF-κB and inhibited its activity. Collectively, these findings suggest that manipulating the redox environment with MnTE-2-PyP⁵⁺ is a promising approach for lymphoma therapy.